Evidence map›Paper›PMID 40738790›Full record

ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Preoperative network activity predicts the response to subthalamic DBS for Parkinson's disease.

Prashin Unadkat, An Vo, Yilong Ma, Chris C Tang, Vijay Dhawan, Martin Niethammer, Nha Nguyen, Shichun Peng, Akash Mishra, Ritesh Ramdhani and 4 more

Abstract read
In one paragraph

Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Prashin UnadkatCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA; Elmezzi Graduate School of Molecular Medicine, Manhasset, NY, USA; Department of Neurosurgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
An VoCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA; Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Yilong MaCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA; Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Chris C TangCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Vijay DhawanCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA; Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Martin NiethammerCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA; Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Department of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Nha NguyenCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Shichun PengCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Akash MishraDepartment of Neurosurgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Ritesh RamdhaniDepartment of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Albert FenoyElmezzi Graduate School of Molecular Medicine, Manhasset, NY, USA; Department of Neurosurgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Institute of Behavioral Science, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Silvia Paola CaminitiDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Daniela PeraniNuclear Medicine Unit, San Raffaele Hospital, Milan, Italy.
David EidelbergCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA; Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Department of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA. Electronic address: deidelberg@northwell.edu.

Funding

Statistics and Data Management CoreP50NS071675 · NINDS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI EIDELBERG, DAVID · 2010 to 2014
$9.3M
Neurovascular Effects of Dopamine Replacement Therapy in Parkinson's DiseaseR01NS105979 · NINDS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI EIDELBERG, DAVID · 2019 to 2023
$3.0M
NINDS NIH HHS P50 NS071675NINDS NIH HHS R01 NS105979
6 · The paper itself

Abstract

Quantitative imaging markers to aid in the selection of Parkinson's disease (PD) patients for surgical interventions such as subthalamic nucleus deep brain stimulation (STN-DBS) are currently lacking. Using metabolic PET and network analysis we identified and validated a treatment-induced topography, termed STN StimNet. Stimulation-mediated changes in network expression correlated with concurrent motor improvement in independent STN-DBS cohorts scanned on and off stimulation. Moreover, STN StimNet measurements off stimulation correlated with local field potentials recorded from the STN, whereas intraoperative modulation of cortical activity by STN stimulation correlated with contributions to the network from corresponding brain regions. These findings suggested that stimulation-mediated clinical responses are influenced by baseline StimNet expression. Indeed, we found that motor outcomes following STN-DBS were predicted by preoperative network expression measured using metabolic PET or resting-state fMRI. To illustrate the potential utility of these measures in selecting optimal candidates for DBS surgery, STN StimNet expression was computed in scans from 175 PD patients (0-21 years from diagnosis). The resulting values were used to identify those individuals likely to derive meaningful benefit from a potential STN-DBS procedure. This approach suggests that preoperative network quantification provides unique information regarding baseline brain circuitry, which may be useful in surgical decision making.

Indexed as

Deep Brain StimulationNerve NetParkinson DiseaseSubthalamic NucleusAdultAgedFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyPreoperative CareTreatment OutcomeBiomarkersBrain networksDeep brain stimulation (DBS)Functional brain imagingParkinson's disease (PD)Subthalamic nucleus (STN)

Identifiers

PMID40738790
PMCPMC12491795

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.